Literature DB >> 18573375

Applications of aptamers in cancer cell biology.

Joseph A Phillips1, Dalia Lopez-Colon, Zhi Zhu, Ye Xu, Weihong Tan.   

Abstract

Identifying cells associated with specific disease states is critically important for the early detection and diagnosis of cancer. To facilitate this task, molecular probes, which bind biomarkers that are either specifically or differentially expressed in diseased cells relative to healthy cells, provide a simple and effective method. This review focuses on the use of DNA aptamers as molecular probes for cancer cells. These aptamers are created by means of the cell-based Systematic Evolution of Ligands by EXponential enrichment (SELEX) process, which uses whole disease cells as targets. We describe at length the steps of the cell-SELEX process and discuss several applications for the aptamers, including profiling leukemia patient samples and discovering cell-surface cancer biomarkers. We conclude with a discussion of an aptamer-conjugated nanoparticle enrichment and detection scheme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573375     DOI: 10.1016/j.aca.2008.05.031

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  24 in total

Review 1.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 2.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

3.  Solvent effect and time-dependent behavior of C-terminus-cysteine-modified cecropin P1 chemically immobilized on a polymer surface.

Authors:  Xiaofeng Han; Lauren Soblosky; Morris Slutsky; Charlene M Mello; Zhan Chen
Journal:  Langmuir       Date:  2011-05-09       Impact factor: 3.882

4.  Identifying protein variants with cross-reactive aptamer arrays.

Authors:  Sara Stewart; Angel Syrett; Arti Pothukuchy; Sancheeta Bhadra; Andrew Ellington; Eric Anslyn
Journal:  Chembiochem       Date:  2011-07-27       Impact factor: 3.164

5.  RNA aptamers inhibit the growth of the fish pathogen viral hemorrhagic septicemia virus (VHSV).

Authors:  Porntep Punnarak; Mudjekeewis D Santos; Seong Don Hwang; Hidehiro Kondo; Ikuo Hirono; Yo Kikuchi; Takashi Aoki
Journal:  Mar Biotechnol (NY)       Date:  2012-04-22       Impact factor: 3.619

Review 6.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

7.  Orientation difference of chemically immobilized and physically adsorbed biological molecules on polymers detected at the solid/liquid interfaces in situ.

Authors:  Shuji Ye; Khoi Tan Nguyen; Andrew P Boughton; Charlene M Mello; Zhan Chen
Journal:  Langmuir       Date:  2010-05-04       Impact factor: 3.882

8.  Aptamer-targeted cell-specific RNA interference.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Silence       Date:  2010-02-01

Review 9.  Receptor-targeted nanocarriers for therapeutic delivery to cancer.

Authors:  Bo Yu; Heng Chiat Tai; Weiming Xue; L James Lee; Robert J Lee
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

10.  Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides.

Authors:  Enid W Choi; Lalitha V Nayak; Paula J Bates
Journal:  Nucleic Acids Res       Date:  2009-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.